Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanthanum carbonate for phosphate control in chronic kidney disease stages 3b-4
ACTRN12610000650099Phase 4Completed
- Sponsor
- Australasian Kidney Trials Network
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial in chronic kidney disease (CKD) comparing Lanthanum carbonate with Matched placebo (2 arms). Primary endpoint: Arterial compliance at 24 months. Started Mar 2012; status: completed.
02
Drugs
lanthanum carbonate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on ACTRN12610000650099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000650099.